In 2021, DKK 1,900 million and DKK 2,200 million and an EBITDA between DKK 100 million and DKK 300 million and Key assumptions Revenue: The low end of the revenue range reflects a scenario where a lockdown due to COVID-19 continues beyond Q1 in key markets like the US and Germany. The higher end of the revenue range reflects a scenario where a gradual reopening will happen in key markets during Q2 and where travel starts picking up again in Q3 and Q4 of 2021. The smallpox and Ebola business are not expected to be impacted by COVID-19. Research and development: Research and development costs of approximately